Medtronic PLC (MDT)
Profitability ratios
Return on sales
| Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Apr 26, 2024 | Jan 31, 2024 | Jan 26, 2024 | Oct 31, 2023 | Oct 27, 2023 | Jul 31, 2023 | Jul 28, 2023 | Apr 30, 2023 | Apr 28, 2023 | Jan 31, 2023 | Jan 27, 2023 | Oct 31, 2022 | Oct 28, 2022 | Jul 31, 2022 | Jul 29, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 46.76% | 62.89% | 53.00% | 53.05% | 45.08% | 45.97% | 45.13% | 44.95% | 44.91% | 45.20% | 46.86% | 46.72% | 46.48% | 46.26% | 45.12% | 43.70% | 43.70% | 43.10% | 41.19% | 43.42% |
| Operating profit margin | 17.76% | 18.21% | 15.76% | 15.57% | 16.18% | 15.91% | 17.77% | 17.30% | 16.79% | 17.20% | 17.06% | 17.42% | 17.79% | 17.82% | 18.45% | 17.59% | 16.95% | 17.69% | 18.28% | 19.96% |
| Pretax margin | 16.78% | 15.73% | 13.10% | 12.97% | 13.52% | 15.12% | 17.47% | 16.81% | 16.13% | 16.60% | 16.49% | 17.02% | 17.55% | 17.59% | 18.22% | 17.33% | 16.48% | 16.90% | 17.31% | 18.86% |
| Net profit margin | 13.90% | 12.83% | 10.46% | 10.71% | 11.53% | 12.49% | 14.04% | 12.52% | 10.94% | 11.60% | 11.86% | 13.15% | 14.45% | 12.55% | 10.88% | 10.03% | 9.19% | 12.56% | 15.83% | 17.41% |
Medtronic PLC has shown a consistent improvement in its profitability ratios over the analyzed period. The Gross Profit Margin has steadily increased from 41.19% in July 31, 2022, to a high of 62.89% in January 31, 2025, indicating the company's ability to efficiently manage production costs and generate revenue.
The Operating Profit Margin has relatively fluctuated but generally maintained an upward trend, with a significant increase seen from 15.57% in July 31, 2024, to 18.21% in January 31, 2025. This suggests that the company has been effectively controlling its operating expenses and improving operational efficiency.
The Pretax Margin has also shown variability but demonstrated an overall increase over the periods analyzed. Starting at 12.97% in July 31, 2024, and reaching 15.73% in January 31, 2025, this ratio indicates Medtronic's ability to generate profits before accounting for taxes.
The Net Profit Margin, which reflects the company's bottom-line profitability, has shown improvement as well. From a low of 9.19% in October 31, 2022, it increased to 13.90% in April 30, 2025. This indicates that Medtronic has been effectively managing its expenses and generating higher net income relative to its revenue.
Overall, the trend in profitability ratios for Medtronic PLC suggests a positive financial performance with improvements in gross, operating, pre-tax, and net profit margins over the analyzed period.
Return on investment
| Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Apr 26, 2024 | Jan 31, 2024 | Jan 26, 2024 | Oct 31, 2023 | Oct 27, 2023 | Jul 31, 2023 | Jul 28, 2023 | Apr 30, 2023 | Apr 28, 2023 | Jan 31, 2023 | Jan 27, 2023 | Oct 31, 2022 | Oct 28, 2022 | Jul 31, 2022 | Jul 29, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 6.50% | 6.72% | 6.06% | 5.95% | 6.16% | 5.96% | 6.22% | 5.98% | 5.79% | 6.04% | 6.24% | 6.38% | 6.50% | 6.33% | 5.94% | 5.60% | 5.37% | 5.70% | 6.20% | 6.86% |
| Return on assets (ROA) | 5.09% | 4.73% | 4.02% | 4.09% | 4.39% | 4.68% | 4.91% | 4.33% | 3.77% | 4.07% | 4.34% | 4.82% | 5.28% | 4.45% | 3.50% | 3.19% | 2.91% | 4.04% | 5.37% | 5.98% |
| Return on total capital | 10.14% | 13.60% | 12.48% | 12.17% | 12.13% | 11.52% | 12.02% | 11.76% | 11.25% | 11.63% | 12.16% | 12.40% | 12.71% | 8.47% | 11.62% | 10.90% | 10.17% | 7.83% | 11.30% | 8.82% |
| Return on equity (ROE) | 9.71% | 8.63% | 7.46% | 7.66% | 7.87% | 8.38% | 8.62% | 7.59% | 6.61% | 7.13% | 7.70% | 8.54% | 9.33% | 7.87% | 6.41% | 5.84% | 5.23% | 7.27% | 9.17% | 10.21% |
Medtronic PLC's profitability ratios show a consistent performance over the past few quarters. The Operating Return on Assets (Operating ROA) has ranged between 5.37% to 6.86% during this period, indicating that for every dollar of assets, the company generates operating income ranging from 5.37 cents to 6.86 cents.
The Return on Assets (ROA) has varied between 2.91% to 5.09% over the same period, reflecting the company's ability to generate profits from its assets, ranging from 2.91 cents to 5.09 cents for every dollar of assets.
The Return on Total Capital has shown a consistent performance, ranging between 7.83% to 13.60%, indicating the company's ability to generate returns for both equity and debt providers, with returns ranging from 7.83 cents to 13.60 cents for every dollar of total capital.
The Return on Equity (ROE) has ranged between 5.23% to 10.21% over the quarters, reflecting the company's efficiency in generating profits from shareholders' equity, with returns ranging from 5.23 cents to 10.21 cents for every dollar of equity invested.
Overall, the profitability ratios suggest that Medtronic PLC has maintained a stable performance in terms of generating returns for its assets, total capital, and equity shareholders over the analyzed period.